U.S Bacterial Conjunctivitis Drugs Market Is Estimated to Reach a Market Worth of USD 439.8 Million in 2024, at a CAGR of 2.7%from 2012 to 2018
According to a new market report published by Persistence Market Research "The U.S Market Study on Bacterial Conjunctivitis Drugs: fluoroquinolones to be the Largest Segment by 2024" the bacterial conjunctivitis drugs market in the U.S. was valued at USD 473.3 million in 2013 and is estimated to reach a market worth of USD 439.8 million in 2024, at a CAGR of2.7%from 2012 to 2018 and (-3.73%) from 2018 to 2024.
View full press release